Certified Global Research Member
Key Questions Answered
- Global Market Outlook
- In-depth analysis of global and regional trends
- Analyze and identify the major players in the market, their market share, key developments, etc.
- To understand the capability of the major players based on products offered, financials, and strategies.
- Identify disrupting products, companies, and trends.
- To identify opportunities in the market.
- Analyze the key challenges in the market.
- Analyze the regional penetration of players, products, and services in the market.
- Comparison of major players’ financial performance.
- Evaluate strategies adopted by major players.
- Recommendations
Why Choose Market Research Future?
- Vigorous research methodologies for specific market.
- Knowledge partners across the globe
- Large network of partner consultants.
- Ever-increasing/ Escalating data base with quarterly monitoring of various markets
- Trusted by fortune 500 companies/startups/ universities/organizations
- Large database of 5000+ markets reports.
- Effective and prompt pre- and post-sales support.
The Spinal Cord Stimulator market segment is projected to be worth USD 4.1 Billion by 2030 up to 8.8% CAGR from 2022 through 2030. The Spinal Cord Stimulator (SCS) Market is shaped by several factors that pull together and foster its expansion. Among the many factors contributing to the growth of the pain management market is the rising burden of chronic pain cases and growing demand for non-pharmacological measures of pain control. In the search for alternatives to traditional pain remedies, spinal cord stimulation has become an alternative therapy that successfully relieves long-term pain. With technology innovations in SCS, new device forms, enhanced programming and wider indications, it is turning out to be a promising treatment option for a wider scope of people.
The SCS market is regulated by certain factors to bring about the safety, efficacy, and compliance of the devices with spinal cord stimulators. The most stringent of the regulations pertain to the approval, manufacturing, and usage of these medical devices and consequently creating the framework of responsible industry practices and patient safety. These regulations ensure also the reliability of SCS procedures while building confidence in healthcare professionals and people in chronic pain too.
The evolution of neuromodulation technologies contributes to these changing dynamics in the SCS marketplace. The ongoing development of next-generation SCS devices that incorporate high-frequency stimulation, closed loop systems and wireless connectivity options strengthen the precision and personalization of pain relief treatments. These technical innovations are intended to help individual clinical cases and improve the results of spinal cord stimulation, which in turn will contribute to the development of technology within the industry.
Economic parameters, for instance, healthcare budgets, affordability of the SCS technologies and cost-effectiveness of pain management methods all play a role in the uptake of spinal cord stimulators. The frontal charges for SCS procedures and devices may not be similar, however the prospect for long term pain relief, reduced health service utilization and enhanced quality of life make them attractive to the healthcare providers and individuals alike who are looking for alternative methods to drugs for pain relief. Economic factors often determine to a large extent, how the market trends emerge and how advanced SCS technologies are made available.
Covered Aspects:
| Report Attribute/Metric | Details |
|---|---|
| Growth Rate | Â Â 8.8% |
Spinal Cord Stimulator Market Highlights:
Global Spinal Cord Stimulator Market Overview
Spinal Cord Stimulator Market Size was valued at USD 2.30 Billion in 2023. The Global Spinal Cord Stimulator industry is projected to grow from USD 2.50 Billion in 2024 to USD 4.81 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 8.99% during the forecast period (2024 - 2032).Spinal cord stimulator (SCS) is a type of implantable neuromodulation device. The device is used to send electric signals to the pain areas of the spinal cord for the treatment of certain pain conditions. SCS is also known as a dorsal column stimulator (DCS) or a pain pacemaker. Increasing demand for minimally invasive procedures, a rise in the number of patients suffering from failed back surgery syndrome, a growing number of patients suffering from chronic & neuropathic pain and rising prevalence of degenerative disc disease (DDD) are the factors that are expected to drive the market growth. As per recent studies, spinal cord stimulation can be used to treat a variety of diseases that result in chronic pain. Treated diagnoses include complex regional pain syndrome type I (45%) and type II (4%), failed back surgery syndrome (FBSS) (33%), visceral pain (5%), neuropathy (10%), and peripheral vascular disease (3%).
As of May 2018, one-third of the global population aged 40 to 59 years have reported moderate to severe degenerative disc disease. Moreover, the growing R&D expenditure by companies to develop innovative spinal cord stimulators and increasing technological advancements are also expected to boost the spinal cord stimulator market growth.
A form of medical gadget known as a spinal cord stimulation device uses electrical impulses to relieve chronic pain in the spinal cord. The system consists of an electrode close to the spinal cord, a wire introduced into the spinal canal, and a small electrical generator. The electrodes are positioned in the epidural area close to the spinal cord, while the generator is inserted beneath the skin. Patients with chronic pain problems like failed back surgery syndrome, complicated regional pain syndrome, and neuropathic pain can relieve their symptoms thanks to the device's electrical impulses, which disrupt the transmission of signals for pain to the brain. A developing neuromodulation treatment delivers tailored electromagnetic or chemical stimuli to a particular neural region.
Spinal cord stimulation, which involves sending electrical stimuli to the spinal cord, is one of the neuromodulation treatments that masks pain. Due to technical improvement, the emergence of legislative guidelines for SCS operations, and the quick uptake of minimally invasive therapies, SCS is drawing more attention globally. The prevalence of chronic pain is on the rise, the population is aging rapidly, technology is advancing, and people are becoming more aware of spinal cord stimulation devices. These are the main reasons influencing the growth of the spinal cord stimulation devices market. The classification of surgical procedures ranged from 1, which denoted urgent procedures like heart transplants, to five, which denoted fully elective procedures like cataract operations.
The level 5 classification of spinal cord stimulation treatments caused many implantations to be postponed, which reduced the need for stimulators. Furthermore, the market is expanding due to technological developments in spinal cord stimulation devices. Modern features like wireless networking, longer-lasting batteries, and better programming are being added to new gadgets. These developments are increasing the use of spinal cord stimulation equipment and enhancing patient outcomes. There will likely be lucrative chances for the growth of the spinal cord stimulation devices marketplace as a result of innovations in the medical device sector that will provide cutting-edge spinal cord stimulation devices to meet the unmet medical demands of a sizable target audience.
Spinal Cord Stimulator Market Influencer
Currently, there are very few medical device companies in the spinal cord stimulator market that are into the manufacturing of spinal cord stimulator devices. This is expected to create lucrative opportunities for other players in the industry to enter the spinal cord stimulator market.
Spinal Cord Stimulator Market Trends
Increasing demand for minimally invasive procedures - Minimally invasive surgery became the most common method of repairing different types of heart and spine in developed countries. As per MRFR analysis, over 50% of spine surgery surgeries are performed using minimally invasive techniques.
Rise in the number of patients suffering from failed back surgery syndrome – As of September 2018, 40% of the patients that suffer from chronic lower back pain have experienced continued pain after the surgery, which is also referred to as failed back surgery syndrome (FBSS).
- Increasing number of patients suffering from chronic & neuropathic pain.
- Rising prevalence of degenerative disc disease.
- Increasing R&D expenditure by companies to develop innovative spinal cord stimulator.
Spinal Cord Stimulator Market Restraints
Stringent government regulations related to product approvals.
Major dependence on traditional therapies for the treatment
Lack of awareness regarding the use of spinal cord stimulators for the treatment of neuropathic pain
The dearth of skilled professionals. For instance, World Health Organization (WHO) estimates that based on a threshold of 4.4 skilled health professionals per 1000 population, the needs-based shortage of health-care workers globally would be about 17.4 million, of which almost 2.6 million are doctors, and over 9 million are nurses and midwives.
Spinal Cord Stimulator Market Segment Insights
Spinal Cord Stimulator Technology Type Insights
Conventional Implantable Pulse Generator (IPG): This segment held the largest market share in 2018 due to its cost-effectiveness and high usage by the hospitals.
Rechargeable Implantable Pulse Generator: This segment is expected to be the fastest-growing during the forecast period owing to the stable product launches of rechargeable IPGs by companies. For instance, Boston Scientific Corporation launched the Spectra Wavewriter SCS system in January 2019 in Europe.
Radiofrequency Stimulator: This type of stimulator also uses rechargeable batteries and is used in patients who suffer from pain in the lower legs and lower back as this device has low power.
Failed Back Surgery Syndrome (FBSS): The segment held the largest spinal cord stimulator market share in 2018 owing to the increasing prevalence of failed back surgery syndrome. In 2017, the prevalence of FBSS was 20.6%. Moreover, FBSS affects approximately 10% to 40% of patients who undergo back surgery.
Spinal Cord Stimulator Application insights
Failed Back Surgery Syndrome (FBSS): The segment held the largest spinal cord stimulator market share in 2018 owing to the increasing prevalence of failed back surgery syndrome. In 2017, the prevalence of FBSS was 20.6%. Moreover, FBSS affects approximately 10% to 40% of patients who undergo back surgery.
Complex Regional Pain Syndrome (CRPS): CRPS generally develops after an injury, surgery, stroke, or heart attack. The condition is also known as RSD or reflex sympathetic dystrophy syndrome. As per studies, the overall incidence rate of complex regional pain syndrome was 26.2 per 100,000 person-years with females affected at least three times more often than males. The highest incidence occurred in females aged 61-70 years (June 2018)
Arachnoiditis: Arachnoiditis is a rare disorder that is caused by the inflammation of the arachnoid, which is a membrane that surrounds and protects the nerves of the spinal cord.
Sciatica: Sciatica or Sciatic neuritis is a type of chronic pain that radiates from the lower back and goes through the hips & buttocks and the legs. The conditions generally affect only one side of the body.
Degenerative Disc Disease (DDD): The segment is expected to grow at the fastest CAGR owing to the rising prevalence of the disease. DDD affects 85% of Americans by the age of 50.
Others: Other conditions include angina, peripheral vascular disease, multiple sclerosis, spinal cord injury, and stump pain, among others.
Hospitals and Clinics: This segment held the largest market share in 2018. Hospitals and clinics are the primary point of care for treatment, which is expected to drive the spinal cord stimulator market growth.
Spinal Cord Stimulator End-User Insights
Hospitals and Clinics: This segment held the largest market share in 2018. Hospitals and clinics are the primary point of care for treatment, which is expected to drive the spinal cord stimulator market growth.
Ambulatory Surgical Centers: The spinal cord stimulator market segment is anticipated to register the fastest CAGR owing to the rising popularity of ambulatory surgical centers for carrying out surgeries in which the patient does not have to stay in the hospital for a longer period.
Others: This includes research and academic institutes, and specialty clinics, among others.
Americas: The largest regional market, owing to the rising prevalence of failed back surgery syndrome and the presence of major players in the market. As of April 2018, in the US, the overall failure rate of lumbar spine surgery was approximately 10% to 46%. Due to this, the number of patients suffering from FBSS is expected to increase continually.
The Inceptiv closed-loop rechargeable spinal cord stimulator (SCS) from Medtronic plc, a leader in healthcare technology, has been given the CE Mark. The initial Medtronic SCS device provides a closed-loop function, which detects each person's biological signals and modifies stimulation as necessary on the fly to keep therapy in sync with daily activities. Mild electrical impulses are delivered to the spinal cord via spinal cord stimulators, which can obstruct pain signals before they enter the brain. Certain motions made by patients throughout their daily activities may cause unpleasant stimulation. This could cause some patients to reduce their device's stimulation output, compromising their therapeutic experience. The neuronal reaction of the body to a stimulus can be detected by Inceptiv 50 times per moment, each minute of every day. Inceptiv automatically reduces stimulation when brain reaction spikes occur, such as when a patient sneezes, coughs, or bends.
Spinal Cord Stimulator Market Regional Insights
Americas: The largest regional market, owing to the rising prevalence of failed back surgery syndrome and the presence of major players in the market. As of April 2018, in the US, the overall failure rate of lumbar spine surgery was approximately 10% to 46%. Due to this, the number of patients suffering from FBSS is expected to increase continually.
Europe: The spinal cord stimulator market in Europe held the second-largest position in 2018 owing to the rising prevalence of neuropathic pain and well-developed infrastructure in the region. As of December 2017, the prevalence of neuropathic pain in the European population was 7%. while 4% of responders had chronic pain secondary to nerve disease and 10% were being treated by neurologists/neurosurgeons
Asia-Pacific: The fastest-growing regional market. The growth of the spinal cord stimulator market in this region is owing to the rapidly growing incidence rate of complex regional pain syndrome and the rising adoption of technologically advanced treatment options by the healthcare providers. As of 2019, the incidence rate of CRPS in South Korea was 29.0 per 100,000 persons.
Middle East & Africa: The spinal cord stimulator market is expected to hold the least market share owing to the poor healthcare infrastructure in the region.
Recent Development
In November 2023,
Announced positive results from the HF10 therapy arm of its Senza SCS System pivotal trial for the treatment of chronic pain. HF10 therapy delivers a new high-frequency waveform aimed at improving pain relief.
Spinal Cord Stimulator Market Key Players
- Boston Scientific Corporation (US)
- Abbott (US)
- Nevro Corp. (US)
- Medtronic (Ireland)
- Stimwave LLC (US)
- Nuvectra (US)
- Beijing PINS Medical Co., Ltd (China)
- Cirtec (US)
- Synapse Biomedical Inc. (US)
- NeuroSigma, Inc. (US)
- Others
Leading companies partner with us for data-driven Insights
Kindly complete the form below to receive a free sample of this Report
Tailored for You
- Dedicated Research on any specifics segment or region.
- Focused Research on specific players in the market.
- Custom Report based only on your requirements.
- Flexibility to add or subtract any chapter in the study.
- Historic data from 2014 and forecasts outlook till 2040.
- Flexibility of providing data/insights in formats (PDF, PPT, Excel).
- Provide cross segmentation in applicable scenario/markets.
